Josep-Maria Ribera, MD, PhD, University of Barcelona, Barcelona, Spain, briefly discusses factors to consider when selecting patients with acute lymphoblastic leukemia (ALL) for stem cell transplantation in the first-line setting. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.